SEC - Agilent AdvanceBio SEC 1.9 μm column

Application Note Biopharma High Resolution Size Exclusion Chromatography Analysis of Small Therapeutic Proteins Authors Sandeep Kondaveeti, Te‑Wei Chu, and Andrew Coffey Agilent Technologies, Inc. Abstract Protein denaturation processes involving aggregation are among the factors impeding the development of stable protein…

Agilent Biocolumns Aggregate/Fragment Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Size Exclusion Chromatography for Biomolecule Analysis - 5991-3651EN 4 Featured Application Notes Elevate Your mAb Aggregate Analysis - 5994-2709EN 1 22 22 High-Resolution, High-Throughput…

Application Note Biopharma/Pharma Robust Wide Pore Size Exclusion Columns for Virus-Like Particles (VLPs) Analysis Using Agilent AdvanceBio SEC column technology Authors Abstract Charu Kumar, Ta-Chen Wei, Andrew Coffey, and Anne Blackwell Agilent Technologies, Inc. Aggregate analysis of VLPs is a…

Agilent-NISTmAb Aggregate and Fragment Analysis Agilent BioHPLC Columns Application Compendium Contents Agilent-NISTmAb Standard (P/N 5191-5744; 5191-5745) was aliquoted from NISTmAb RM 8671 batch. Quality control (QC) testing is performed using Agilent LC-MS system. QC batch release test includes aggregate profile,…